Kensaku Kasuga

3.6k total citations
74 papers, 1.2k citations indexed

About

Kensaku Kasuga is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Kensaku Kasuga has authored 74 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Physiology, 25 papers in Molecular Biology and 25 papers in Neurology. Recurrent topics in Kensaku Kasuga's work include Alzheimer's disease research and treatments (35 papers), Dementia and Cognitive Impairment Research (17 papers) and Parkinson's Disease Mechanisms and Treatments (14 papers). Kensaku Kasuga is often cited by papers focused on Alzheimer's disease research and treatments (35 papers), Dementia and Cognitive Impairment Research (17 papers) and Parkinson's Disease Mechanisms and Treatments (14 papers). Kensaku Kasuga collaborates with scholars based in Japan, United States and Ireland. Kensaku Kasuga's co-authors include Takeshi Ikeuchi, Masatoyo Nishizawa, Takayoshi Tokutake, Osamu Onodera, Ryozo Kuwano, Akinori Miyashita, Toshiyuki Tezuka, Masataka Kikuchi, Norikazu Hara and Hiroyuki Kaneko and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Kensaku Kasuga

64 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kensaku Kasuga 572 420 386 279 203 74 1.2k
Nobutaka Sakae 547 1.0× 517 1.2× 807 2.1× 342 1.2× 329 1.6× 53 1.8k
Teemu Natunen 481 0.8× 453 1.1× 164 0.4× 168 0.6× 215 1.1× 44 1.1k
Erika Bereczki 623 1.1× 510 1.2× 192 0.5× 280 1.0× 191 0.9× 40 1.4k
Hiroyuki Hatsuta 914 1.6× 914 2.2× 856 2.2× 283 1.0× 327 1.6× 48 2.2k
Chang‐En Yu 840 1.5× 713 1.7× 223 0.6× 248 0.9× 193 1.0× 30 1.5k
Siegfried Kösel 451 0.8× 621 1.5× 374 1.0× 300 1.1× 338 1.7× 35 1.3k
Olivia Belbin 875 1.5× 550 1.3× 248 0.6× 174 0.6× 264 1.3× 51 1.4k
Milène Vandal 890 1.6× 473 1.1× 275 0.7× 382 1.4× 351 1.7× 41 1.9k
Yuka A. Martens 748 1.3× 459 1.1× 178 0.5× 176 0.6× 490 2.4× 29 1.4k
John F. Ervin 542 0.9× 384 0.9× 181 0.5× 239 0.9× 194 1.0× 27 1.0k

Countries citing papers authored by Kensaku Kasuga

Since Specialization
Citations

This map shows the geographic impact of Kensaku Kasuga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensaku Kasuga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensaku Kasuga more than expected).

Fields of papers citing papers by Kensaku Kasuga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensaku Kasuga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensaku Kasuga. The network helps show where Kensaku Kasuga may publish in the future.

Co-authorship network of co-authors of Kensaku Kasuga

This figure shows the co-authorship network connecting the top 25 collaborators of Kensaku Kasuga. A scholar is included among the top collaborators of Kensaku Kasuga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensaku Kasuga. Kensaku Kasuga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsukie, Tamao, Kiyoshi Onda, Yasuo Miyagi, et al.. (2025). Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer’s Disease. Biomolecules. 15(10). 1367–1367.
2.
Yasuno, Fumihiko, Atsushi Watanabe, Yasuyuki Kimura, et al.. (2025). Plasma IL-6 Levels as a Biomarker for Behavioral Changes in Alzheimer’s Disease. NeuroImmunoModulation. 32(1). 233–244.
3.
Sato, Kenichiro, Yoshiki Niimi, Ryoko Ihara, et al.. (2025). Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(4). e70167–e70167.
4.
Sato, Kenichiro, Yoshiki Niimi, Ryoko Ihara, et al.. (2025). Real‐world lecanemab adoption in Japan 1 year after launch: Insights from 311 specialists on infrastructure and reimbursement barriers. Alzheimer s & Dementia. 21(10). e70652–e70652.
5.
Kimura, Atsushi, Masahiro Hatakeyama, Masaki Watanabe, et al.. (2024). A case of cerebral amyloid angiopathy with ipsilateral tau and contralateral amyloid PET uptake related to cadaveric dura mater implanted in childhood. European Journal of Nuclear Medicine and Molecular Imaging. 52(8). 2737–2739.
6.
Kasuga, Kensaku, et al.. (2024). Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy. Brain Sciences. 14(9). 859–859. 1 indexed citations
7.
Sato, Kenichiro, Yoshiki Niimi, Ryoko Ihara, et al.. (2024). Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer’s Disease in Japan. Alzheimer s Research & Therapy. 16(1). 205–205. 6 indexed citations
8.
Kasuga, Kensaku, Noriko Isoo, Toshihiro Hayashi, et al.. (2023). Soluble form of the APP fragment, sAPPβ, positively regulates tau secretion. Neuroscience Research. 193. 63–70. 2 indexed citations
9.
Kommaddi, Reddy Peera, Aditi Verma, Graciela Muñiz‐Terrera, et al.. (2023). Sex difference in evolution of cognitive decline: studies on mouse model and the Dominantly Inherited Alzheimer Network cohort. Translational Psychiatry. 13(1). 123–123. 11 indexed citations
10.
Kasuga, Kensaku, Tamao Tsukie, Masataka Kikuchi, et al.. (2023). Application of AT(N) classification using two CSF A‐markers and two CSF N‐markers to Alzheimer’s Clinical Syndrome (ACS) and non‐ACS. Alzheimer s & Dementia. 19(S14). 1 indexed citations
11.
Kasuga, Kensaku, Masataka Kikuchi, Tamao Tsukie, et al.. (2022). Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid. BMJ Neurology Open. 4(2). e000321–e000321. 11 indexed citations
12.
Nosheny, Rachel L., Rebecca E. Amariglio, Sietske A.M. Sikkes, et al.. (2022). The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12357–e12357. 23 indexed citations
13.
Kandiah, Nagaendran, Seong Hye Choi, Chaur‐Jong Hu, et al.. (2022). Current and Future Trends in Biomarkers for the Early Detection of Alzheimer’s Disease in Asia: Expert Opinion. Journal of Alzheimer s Disease Reports. 6(1). 699–710. 14 indexed citations
14.
Kikuchi, Masataka, Kaori Kobayashi, Kensaku Kasuga, et al.. (2022). Identification of mild cognitive impairment subtypes predicting conversion to Alzheimer’s disease using multimodal data. Computational and Structural Biotechnology Journal. 20. 5296–5308. 7 indexed citations
15.
Hirose, Genjiro, et al.. (2021). Follow-up study of a patient with early onset cerebral amyloid angiopathy following childhood cadaveric dural graft. Acta Neurochirurgica. 163(5). 1451–1455. 13 indexed citations
16.
Nakajima, Madoka, Masakazu Miyajima, Ikuko Ogino, et al.. (2018). Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus. Journal of Alzheimer s Disease. 66(1). 319–331. 24 indexed citations
17.
Ohtsubo, Ken’ichi, Sumiko Nakamura, Takashi Hara, et al.. (2018). Trial for the Development of Bio-Functional Foods to Prevent Diabetes and Dementia Using a High-Pressure Treatment. 5(1). 22–30. 3 indexed citations
18.
Tokutake, Takayoshi, Akihide Koyama, Kensaku Kasuga, et al.. (2014). ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA. Biochemical and Biophysical Research Communications. 456(1). 482–488. 36 indexed citations
19.
Ikeuchi, Takeshi, Toru Imamura, Yasuhiro Kawase, et al.. (2011). Evidence for a Common Founder and Clinical Characteristics of Japanese Families with the MAPT R406W Mutation. Dementia and Geriatric Cognitive Disorders Extra. 1(1). 267–275. 12 indexed citations
20.
Ikeuchi, Takeshi, Akiyoshi Kakita, Atsushi Shiga, et al.. (2008). Patients Homozygous and Heterozygous for SNCA Duplication in a Family With Parkinsonism and Dementia. Archives of Neurology. 65(4). 514–514. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026